NasdaqGS - Nasdaq Real Time Price USD

Sotera Health Company (SHC)

Compare
16.76 +0.17 (+1.02%)
At close: September 27 at 4:00 PM EDT
16.76 0.00 (0.00%)
After hours: September 27 at 4:03 PM EDT
Loading Chart for SHC
DELL
  • Previous Close 16.59
  • Open 16.64
  • Bid 16.75 x 100
  • Ask 16.77 x 600
  • Day's Range 16.54 - 16.86
  • 52 Week Range 10.71 - 17.44
  • Volume 1,092,469
  • Avg. Volume 1,249,755
  • Market Cap (intraday) 4.747B
  • Beta (5Y Monthly) 2.07
  • PE Ratio (TTM) 119.71
  • EPS (TTM) 0.14
  • Earnings Date Oct 30, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 16.75

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

soterahealth.com

3,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SHC

View More

Performance Overview: SHC

Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SHC
0.53%
S&P 500
20.30%

1-Year Return

SHC
9.83%
S&P 500
34.27%

3-Year Return

SHC
35.96%
S&P 500
28.79%

5-Year Return

SHC
37.93%
S&P 500
61.30%

Compare To: SHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SHC

View More

Valuation Measures

Annual
As of 9/27/2024
  • Market Cap

    4.75B

  • Enterprise Value

    6.85B

  • Trailing P/E

    119.71

  • Forward P/E

    20.45

  • PEG Ratio (5yr expected)

    1.70

  • Price/Sales (ttm)

    4.33

  • Price/Book (mrq)

    11.23

  • Enterprise Value/Revenue

    6.24

  • Enterprise Value/EBITDA

    16.43

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    3.65%

  • Return on Assets (ttm)

    7.66%

  • Return on Equity (ttm)

    9.53%

  • Revenue (ttm)

    1.1B

  • Net Income Avi to Common (ttm)

    39.94M

  • Diluted EPS (ttm)

    0.14

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    246.58M

  • Total Debt/Equity (mrq)

    555.18%

  • Levered Free Cash Flow (ttm)

    148.61M

Research Analysis: SHC

View More

Company Insights: SHC

Research Reports: SHC

View More

People Also Watch